Pierre-Olivier Beckers-Vieujant and Didier Smits will not

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Pierre-Olivier Beckers-Vieujant and Didier Smits will not stand for renewal at the expiration of their mandate as Directors of Delhaize Group

BRUSSELS, Belgium, March 5, 2015 (GLOBE NEWSWIRE) -- As part of the regular process of reviewing the Board's composition, Delhaize Group announced today that Pierre-Olivier Beckers-Vieujant and Didier Smits have informed the Board that they will not stand for renewal when their current mandates expire at the shareholders' meeting to be held on May 28, 2015. The Company is in advanced stages of discussion with candidates for election at the Ordinary Shareholders' Meeting.  

Baron Beckers-Vieujant has served as a director of Delhaize Group since 1995 and was President and Chief Executive Officer of Delhaize Group from 1999 until 2013. Under Mr. Beckers' leadership, Delhaize Group increased its international presence and evolved itself into an integrated group and leading food retailer.

Mats Jansson, Chairman of the Board of Directors, said: "Pierre-Olivier has worked for Delhaize for more than 30 years. For the last 15 years, he has led both the company and served the Board of Directors. He has shown tremendous leadership in running the business during challenging times and has always displayed very strong values and great respect for people. A number of significant initiatives started under his leadership are beginning to bear fruit today and position us well for sustainable growth. I would like to thank him and wish him well for the future."

Didier Smits has served on the Board of Directors since 1996.

"I would like to thank Didier for his 19 years of service to the Delhaize Group Board of Directors. I have appreciated his loyalty, his thoughtful comments, and his integrity. His contribution to the Board was valued and will be missed," said Mr. Jansson.

  • Delhaize Group

Delhaize Group is a Belgian international food retailer present in seven countries on three continents. At the end of 2014, Delhaize Group's sales network consisted of 3 402 stores. In 2014, Delhaize Group recorded €21.4 billion ($29.4 billion) in revenues and €89 million ($118 million) net profit (Group share). At the end of 2014, Delhaize Group employed approximately 150 000 people. Delhaize Group's stock is listed on NYSE Euronext Brussels (DELB) and the New York Stock Exchange (DEG).

  •   Contacts

Investor Relations: +32 2 412 21 51
Media Relations: +32 2 412 86 69

cautionary note regarding forward looking statements

Statements that are included or incorporated by reference in this press release and other written and oral statements made from time to time by Delhaize Group and its representatives, other than statements of historical fact, which address activities, events and developments that Delhaize Group expects or anticipates will or may occur in the future, including, without limitation, changes in the composition of the Board of Directors, are "forward-looking statements" within the meaning of the U.S. federal securities laws that are subject to risks and uncertainties. These forward-looking statements generally can be identified as statements that include phrases such as "guidance," "outlook," "projected," "believe," "target," "predict," "estimate," "forecast," "strategy," "may," "goal," "expect," "anticipate," "intend," "plan," "foresee," "likely," "will," "should" or other similar words or phrases. Although such statements are based on current information, actual outcomes and results may differ materially from those projected depending upon a variety of factors, including, but not limited to, changes in the general economy or the markets of Delhaize Group, in strategy, in consumer spending, in inflation or currency exchange rates or in legislation or regulation; competitive factors; adverse determination with respect to claims; inability to timely develop, remodel, integrate, open, convert or close stores; and supply or quality control problems with vendors. Additional risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements are described in Delhaize Group's most recent Annual Report on Form 20-F and other filings made by Delhaize Group with the U.S. Securities and Exchange Commission, which risk factors are incorporated herein by reference. Delhaize Group disclaims any obligation to update developments of these risk factors or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments.

HUG#1899571

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 4

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Mouser Electronics Invites Engineers to Innovation Showcase

Updated Category News Views 56

Mouser Electronics planned to make waves at the Embedded World North America 2024, taking place from October 8 to 10. This inaugural event aimed to gather the crème de la crème of the embedded community under one roof, offering a fertile ground for innovation and knowledge exchange. Mouser's Showcase: What to Expect? With industry experts set to share insights through...

Continue Reading
Exploring the Growth Potential of the Exosome Research Market

Updated Category News Views 165

Exploring the Exosome Research Market Trends The global exosome research market is on an impressive trajectory, with projections estimating its value to reach around USD 961.41 million in the next decade. The growth is attributed to a staggering compound annual growth rate (CAGR) of approximately 17.47% during the period from 2025 to 2034. In 2024, the market was valued...

Continue Reading
Vivakor Engages in $3.5 Million Stock Offer for Growth

Updated Category News Views 145

Vivakor Engages in $3.5 Million Stock Offer for Growth Vivakor, Inc. (NASDAQ: VIVK), a company specializing in integrated energy infrastructure and environmental services, has recently announced a significant move in its financing strategy. This announcement involves a registered direct offering, through which the company anticipates raising approximately $3.5 million....

Continue Reading
BlackRock TCP Capital Corp. Gets Credit Ratings Boost

Updated Category News Views 115

In the gritty world of finance, ratings can make or break a company’s standing in the eyes of investors. Recently, BlackRock TCP Capital Corp. (NASDAQ: TCPC) snagged a much-coveted upgrade from Kroll Bond Rating Agency (KBRA), signaling robust operational health intertwined with strategic smarts. The new issuer and senior unsecured debt ratings of BBB- come laced with a...

Continue Reading
Investor Sentiment Shifts Amid Oil Price Concerns for ExxonMobil

Updated Category News Views 140

Falling Oil Prices Put Pressure on ExxonMobil ExxonMobil (NYSE: XOM) slipped 3.1% in a choppy trading session, giving back not only today’s gains but part of yesterday’s progress as well. The company’s share price often moves with crude, and this time that link is clear. What’s different now is that broader market forces are piling on, amplifying the slide and...

Continue Reading